Загрузка...

RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute  ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: V. B. Kostogryz
Формат: Artigo
Язык:Inglês
Опубликовано: Stolichnaya Izdatelskaya Kompaniya 2017-03-01
Серии:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Предметы:
Online-ссылка:https://www.rpcardio.com/jour/article/view/1416
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!